Gongwin Biopharm Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 14, 2022 at 04:14 am EDT
Gongwin Biopharm Holdings Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1.14 million compared to TWD 0.833 million a year ago. Net loss was TWD 121.58 million compared to TWD 93.07 million a year ago. Basic loss per share from continuing operations was TWD 1.11 compared to TWD 0.89 a year ago.